Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Safestore Q125 revenues grow

(Sharecast News) - Self storage firm Safestore said on Thursday that it had delivered "improving like-for-like growth" across all markets during Q1, supported by growth from opened developments. Safestore said total revenues were up 2.6% at £56.7m in Q125, while closing occupancy increased 4.1% to 6.36m square feet and maximum lettable area grew 8.2% to 8.90m square feet.

On a like-for-like basis, revenues were up 1.7% at £55.8m, closing occupancy was up 1.4%, and REVPAF improved 1.2%.

However, total group closing occupancy was down 2.8 points at 71.5%, average storage rates fell 1% to £29.76 and revenue per available square foot slipped 4.5% to £25.63.

Chief executive Frederic Vecchioli said: "We are pleased to see like-for-like occupancy in the UK continuing the improving trajectory we saw in the second half of last year led by strong domestic demand with space occupied by these customers closing the quarter 7.3% ahead of last year.

"Whilst there remain macroeconomic uncertainties, we are confident of the position of the group to realise the opportunities for growth across our markets from both our existing portfolio and our development pipeline."

As of 0900 GMT, Safestore shares were up 2.98% at 601.90p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.